Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04319783 |
Title | Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA (DECREASE) |
Acronym | DECREASE |
Recruitment | Recruiting |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Trans Tasman Radiation Oncology Group |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | AUS |